Tag: Regulatory measures

Browse our exclusive articles!

Elon Musk Aims to Create TruthGPT – A Safer Version of ChatGPT

. Elon Musk, technology entrepreneur and innovator, is leading the charge to create safeguards against the potential risks of artificial intelligence. Co-founder of Apple, Tesla and SpaceX, he is joined by over 100 signers of an open letter calling for a six-month pause on AI experiments. Musk also hopes to use regulation, similar to the FDA, to increase the chances of AI benefiting humans. He is developing his own AI, TruthGPT, to actively seek the truth beyond the "political correctness" of existing products like ChatGPT. A mission driven by a passion to bring innovation to the world.

Altman’s Response to Musk and Other Tech Leaders Calling for AI Pause

OpenAI's AI chatbot ChatGPT is pushing the boundaries of technology while Microsoft and Google use it in their own chatbots. Elon Musk, Steve Wozniak and other academics wrote an open letter recently asking for AI research pause which resulted in over 25,000 people signing it. OpenAI CEO Sam Altman discussed the letter at an MIT event and suggested guidelines and security measures for independent researchers while developing AI. OpenAI is at the forefront of conversation surrounding the ethical development of AI.

Popular

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.

Subscribe

spot_imgspot_img